Bartell upgrades photo developing to Kodak APEX
ROCHESTER, N.Y. — Seattle-based regional retail pharmacy Bartell Drugs has replaced its in-store photo processing lab systems with Kodak Adaptive Picture Exchange, Kodak said.
The upgrade converts Bartell’s processing lab systems from silver halide "wet lab" technology to APEX thermal dry labs.
"Meeting customer demand for new and exciting photo products, while achieving speed and efficiency in the fulfillment process is a strategic business initiative for Bartell Drugs," Bartell SVP merchandising Ron Miller said. "Kodak has helped us every step of the way. Our new APEX fleet not only opens the door to a broader and more profitable in-store product portfolio; it proceeds the pathway for Bartell Drugs stores to become Web-based photo fulfillment centers."
Clif Bar targets college students through social media
EMERYVILLE, Calif. — Clif Bar on Thursday will begin rewarding college students who follow the brand through social media with a Clif Bar Energy Pack that includes Clif Bar bars, fitness tips, water bottles and other items for outdoor recreation.
“Clif Bar wants college students to know that getting outdoors for an active study break isn’t just a good idea for physical health, but can help you stay mentally sharp in the classroom," said Carly Lutz, brand director at Clif brands.
Energy Packs will go to college students who post their active study breaks on Twitter at @ClifBar using the hashmark #StudyBreak.
Research suggests that as many as 70% of college students gain a significant amount of weight between the start of college and sophomore year, Clif Bar noted. In addition to the brain benefits of exercise, burning just an extra 143 calories per day can mean 15 fewer pounds at the end of one year.
Insight buys Monistat; rounds out women’s health portfolio
LANGHORNE, Pa. — Insight Pharmaceuticals recently acquired the Monistat North American brand portfolio from McNeil and is establishing itself as the premier distributor of women’s health over-the-counter products.
“The acquisition of Monistat demonstrates our company’s increased presence in and dedication to the vital category of women’s health," Insight CEO Gary Downing said. "This is a very important category to us and our retail partners, and is a key part of our growth strategy going forward," he said. “This acquisition, along with e.p.t, has increased our revenues by nearly four times in the last 12 months.”
Additionally, as part of the e.p.t transaction, Insight acquired the Uristat urinary pain treatment brand and is preparing to relaunch that brand. “We are excited to bring the Uristat brand back to consumers," Downing said. "The acquisition of Monistat and e.p.t, the relaunch of Uristat, in addition to our vast portfolio, further defines our presence within OTC and the women’s health category. Women’s health is an exciting segment and we are eager to make an impact in this category.”
The Monistat brand created the vaginal antifungal category in 1974 as a pharmaceutical, and made the Rx-to-OTC crossover in 1991.
In connection with the transaction, Ontario Teachers’ Pension Plan, through its private equity group Teachers’ Private Capital, has joined Swander Pace Capital as an equity investor in Insight Pharmaceuticals.